Trial
NCT01954082
Inositol to Reduce Retinopathy of Prematurity
Phase IIITERMINATEDSAFETYConfidence: HIGH
Sponsor
NICHD Neonatal Research Network
Collaborators
National Eye Institute (NEI); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Condition
Retinopathy of Prematurity (ROP)
Intervention
myo-Inositol 5% Injection
Why stopped
Study terminated due to safety concerns; participant follow up will continue until March 2018
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-03-22